业务发展总监 - CDMO
Business Development Director - CDMO
职位地点：远程办公。候选人需位于美国且靠近主要机场。
可变薪资计划：120,000美元
RTI Surgical现已更名为Evergen！
此次品牌重塑反映了我们在再生医学领域作为领先CDMO的战略演变，也标志着公司过去一年的重大进展，包括成功收购了位于印第安纳州的Cook Biotech和明尼苏达州的Collagen Solutions。我们的新品牌形象强调了我们独特的定位——唯一一家能够规模化提供完整同种异体和异种生物材料组合的CDMO。了解更多：
职位概述：业务发展总监将负责推动异种移植物生物材料的B2B增长，重点在于新鲜组织、固定组织以及基于胶原蛋白的解决方案，覆盖脊柱、运动与骨科、心脏、整形与重建手术等关键临床领域。该职位需要在CDMO环境中具备异种移植物处理、应用及价值主张的深厚专业知识。理想的候选人应具有业务发展的成功经验，特别是在CDMO领域，并对深入了解客户业务和推进医疗技术充满热情。
主要职责：
- 针对开发使用异种移植物生物材料（新鲜组织、固定组织和胶原蛋白）的公司进行战略目标筛选，识别与我们加工和制造能力相匹配的机会。
- 制定关键客户策略，以满足客户在异种移植物采购、加工和商业化方面的需求，将Evergen定位为战略CDMO合作伙伴。
- 建立并维护与现有和潜在客户的良好关系，确保深入了解他们的需求和内部流程。
- 协调跨职能合作（研发、法规和制造），开发并交付定制化的异种移植物解决方案。
- 将异种移植物平台能力（如去细胞化、固定、胶原蛋白加工）转化为客户特定的价值主张。
- 识别并塑造异种移植物材料可以替代或超越其他生物材料的机会，为客户带来差异化优势。
- 主导谈判并完成交易，确保对公司有利的条款和客户高度满意。
- 监测市场趋势和竞争对手活动，识别增长和差异化的机遇。
- 准备并代表公司在行业活动中进行展示。
查看英文原文
Location:Remote. Candidate to be located in the US and near a major airport.
Variable Comp Plan: $120,000.00
RTI Surgical is now Evergen!
This rebrand reflects our strategic evolution as a leading CDMO in regenerative medicine and comes at the end of a significant year for the business, including the successful acquisitions of Cook Biotech in IN. and Collagen Solutions, MN. Our new brand identity emphasizes our unique positioning as the only CDMO offering a comprehensive portfolio of allograft and xenograft biomaterials at scale. Learn more:
Position Overview:The Business Development Director will be responsible for driving B2B growth in xenograft biomaterials, with a focus on fresh tissue, fixed tissue, and collagen-based solutions across key clinical segments including Spine, Sports & Orthopedics, Cardiac, and Plastic & Reconstructive surgery. This role requires deep expertise in xenograft processing, applications, and value propositions within a CDMO environment. The ideal candidate will have a proven track record in business development, particularly within the CDMO space, and a passion for deeply understanding their clients’ business and advancing medical technologies.
Key Responsibilities:
- Prospect strategic targets with a focus on companies developing products utilizing xenograft biomaterials (fresh tissue, fixed tissue, and collagen), identifying opportunities aligned with our processing and manufacturing capabilities.
- Develop Key Account Strategies aligned to clients’ xenograft sourcing, processing, and commercialization needs, positioning Evergen as a strategic CDMO partner.
- Build and maintain strong relationships with existing and potential clients, ensuring a deep understanding of their requirements and internal processes.
- Orchestrate cross-functional collaboration (R&D, regulatory, and manufacturing) to develop and deliver customized xenograft-based solutions.
- Translate xenograft platform capabilities (e.g., decellularization, fixation, collagen processing) into customer-specific value propositions.
- Identify and shape opportunities where xenograft materials can replace or outperform alternative biomaterials, driving differentiation for customers.
- Lead negotiations and close deals, ensuring favorable terms for the company and high levels of client satisfaction.
- Monitor market trends and competitor activities to identify opportunities for growth and differentiation.
- Prepare for and represent the company at industry conferences, trade shows, and other networking events to promote our capabilities and expand our client base.
- Prepare and present regular reports on business development activities, pipeline status, and sales performance to senior management.
- Leverage CRM tools to maintain documentation of account planning, prospects, and pipeline development.
Qualifications:
- Bachelor's degree in Business Administration, Marketing, or a related field; advanced degree preferred.
- Minimum of 4 years of experience in business development, sales, or a related role within the medical device industry, including at least 2 years within a medical device CDMO environment.
- Deep understanding of xenograft biomaterials, including fresh tissue, fixed tissue, and collagen (fibrillar, solubilized, or formulated), and their applications in medical devices.
- Experience working with xenograft sourcing, processing, or manufacturing (e.g., decellularization, sterilization, or collagen processing).
- Proven track record of achieving sales targets and driving revenue growth.
- Excellent communication, negotiation, and interpersonal skills.
- Ability to work collaboratively with cross-functional teams and manage multiple projects simultaneously.
- Strategic thinker with strong analytical and problem-solving skills.
- Willingness to travel as needed to meet with clients and attend industry events.
Preferred Qualifications:
- Experience with xenograft-based product development or commercialization within a CDMO or OEM environment.
- Familiarity with regulatory and quality considerations specific to xenograft biomaterials.
- Established network of contacts within the medical device industry.
- Clinical expertise in focus market segments: Spine, Sports and Orthopedics, Cardiac, or Plastic and Reconstructive Surgery.
Why Join Us:
- Opportunity to shape and scale a leading xenograft CDMO platform across fresh tissue, fixed tissue, and collagen biomaterials.
- Collaborative and innovative work environment.
- Competitive salary and benefits package.
- Chance to make a significant impact on patient outcomes through advanced biomaterial solutions.
Our Values at Evergen:
•Accountable: We own our actions
•Agile: We embrace change
•Growth Mindset: We learn continuously
- Customer-Centric: We put customers first
•Inclusive: Every voice matters
Evergen is committed to creating an inclusive environment where diverse perspectives drive innovation and success.
About Our Ownership
Montagu Private Equity acquired RTI Surgical in 2020 and continues to support Evergen’s transformation and long-term growth strategy.
Originally posted on Himalayas